🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Semaglutide cardiovascular benefit: SELECT trial deep dive — looking for input Page 6

Semaglutide cardiovascular benefit: SELECT trial deep dive — looking for input

MaxMetOK Tue, Dec 17, 2024 at 2:04 PM 56 replies 2,950 viewsPage 6 of 12
B12Beth
Member
289
890
Oct 2024
Maryland
Jan 1, 2025 at 5:35 PM#26
BiostatsBrad said:
Worth knowing that the injection site changes very little.

Senior perspective on cardiovascular risk: I'm 70 years old and started this journey skeptically. My cardiologist recommended it after years of failed interventions.

14 months later: down 48 lbs, more mobile, pain reduced, medications simplified. My quality of life has improved dramatically. I wish this existed 20 years ago.

To other older adults hesitating: the SELECT trial proved benefit in our age group. You deserve to feel good in your body regardless of age.

17 15GraceAZ_72, carl_compliance, DanielChem_CHI and 14 others
Reply Quote Save Share Report
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Jan 3, 2025 at 1:32 AM#27
BiostatsBrad said:
Worth knowing that the injection site changes very little.

I want to bring up the cardiovascular angle on cardiovascular risk.

The SELECT trial demonstrated a 20% reduction in MACE with semaglutide 2.4mg[1]. This is practice-changing because the CV benefit appears to be independent of the degree of weight loss — suggesting direct vascular and anti-inflammatory mechanisms.

For cardiovascular risk, this means we need to think beyond the primary outcome and consider the cardiovascular implications. The all-cause mortality reduction (HR 0.81) is the most clinically meaningful signal.

References:
[1] Lincoff AM, et al. N Engl J Med. 2023;389(24):2221-2232.
18 16Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 15 others
Reply Quote Save Share Report
PharmD_Rodriguez
Senior Member
3,456
14,567
Jan 2024
Miami, FL
Jan 4, 2025 at 9:28 AM#28
BiostatsBrad said:
Worth knowing that the injection site changes very little.

Saving this. It is the first explanation that did not require me to already understand it. Taking it to my next appointment.

19 17robert_kc, dan_philly, MeganSA_TX and 16 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
Jan 5, 2025 at 5:24 PM#29

Adding the clinical framing, because it changes how the question reads.

SUSTAIN-6 was the first CVOT to show cardiovascular benefit with semaglutide, relevant to cardiovascular risk. In 3,297 T2DM patients with high CV risk: MACE HR 0.74 (95% CI 0.58-0.95, p=0.02)[1].

Notable: the retinopathy signal in SUSTAIN-6 (HR 1.76) was subsequently attributed to rapid A1C reduction in patients with pre-existing retinopathy — not a direct drug effect. This has been confirmed in longer-term follow-up studies.

References:
[1] Marso SP, et al. N Engl J Med. 2016;375(19):1834-1844.
Last edited: Jan 5, 2025 at 7:24 PM
20 18BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 17 others
Reply Quote Save Share Report
MaxMetOK
Member
312
1,123
Dec 2024
Oklahoma
Jan 7, 2025 at 1:19 AM#30

OP back with an update, since a thread like this is useless without one.

Update since I posted: I held at 1.7mg for a further twelve weeks and lost another 4kg slowly, which settles it for me. I was escalating because the number was available, not because I had stopped responding.

42 15PurityPaulOR, MaxMetOK, MounjBrad and 39 others
Reply Quote Save Share Report
14567812

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register